Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2010, Article ID 638379, 3 pages
Case Report

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease

1Memory Clinic, M51, Department of Geriatric Medicine, Karolinska University Hospital, Huddinge, 17176 Stockholm, Sweden
2Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80 Mölndal, Sweden

Received 26 August 2010; Accepted 24 November 2010

Academic Editor: Akihiko Takashima

Copyright © 2010 Niels Andreasen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Kaj Blennow, Henrik Zetterberg, and Anne M. Fagan, “Fluid Biomarkers in Alzheimer Disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 9, 2012. View at Publisher · View at Google Scholar
  • Niklas Mattsson, Erik Portelius, Kaj Blennow, and Henrik Zetterberg, “Cerebrospinal fluid biomarkers to monitor treatment effects in Alzheimer’s disease and related conditions,” Neurodegenerative Disease Management, vol. 2, no. 1, pp. 117–123, 2012. View at Publisher · View at Google Scholar
  • Robert C Bransfield, “The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms.,” The open neurology journal, vol. 6, pp. 88–93, 2012. View at Publisher · View at Google Scholar
  • Kaj Blennow, Harald Hampel, and Henrik Zetterberg, “Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Niklas Mattsson, and Henrik Zetterbergpp. 131–157, 2014. View at Publisher · View at Google Scholar